Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ARKADENS FYSIOTERAPI & SUNDHEDSCENTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.0% 1.1% 1.3% 0.9% 1.0% 1.6% 5.8% 5.8%   Credit score (0-100)   89 86 80 88 87 73 40 40   Credit rating   A A A A A A BBB BBB   Credit limit (kDKK)   349.6 286.7 112.7 520.6 444.1 13.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   16,284 16,865 17,214 18,554 20,765 20,839 0.0 0.0   EBITDA   1,623 1,956 1,913 1,789 1,715 1,696 0.0 0.0   EBIT   1,243 1,649 1,614 1,535 1,568 1,536 0.0 0.0   Pre-tax profit (PTP)   1,214.8 1,653.2 1,673.1 1,570.4 1,495.4 980.3 0.0 0.0   Net earnings   942.3 1,273.8 1,297.9 1,219.7 1,140.1 631.8 0.0 0.0   Pre-tax profit without non-rec. items   1,215 1,653 1,673 1,570 1,495 980 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   862 854 594 506 505 713 0.0 0.0   Shareholders equity total   1,805 2,079 2,377 2,597 2,514 1,946 746 746   Interest-bearing liabilities   1,635 1,912 31.0 31.9 1,198 2,318 319 319   Balance sheet total (assets)   5,665 7,212 7,992 6,836 7,761 8,154 1,065 1,065   Net Debt   1,571 1,901 -1,392 -648 932 1,986 319 319     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   16,284 16,865 17,214 18,554 20,765 20,839 0.0 0.0   Gross profit growth   -5.9% 3.6% 2.1% 7.8% 11.9% 0.4% -100.0% 0.0%   Employees   35 39 35 35 36 35 0 0   Employee growth %   6.1% 11.4% -10.3% 0.0% 2.9% -2.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,665 7,212 7,992 6,836 7,761 8,154 1,065 1,065   Balance sheet change%   -14.8% 27.3% 10.8% -14.5% 13.5% 5.1% -86.9% 0.0%   Added value   1,623.3 1,956.2 1,913.4 1,789.3 1,823.0 1,696.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -624 -319 -564 -347 -153 46 -713 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.6% 9.8% 9.4% 8.3% 7.6% 7.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   21.6% 27.0% 22.8% 22.0% 21.9% 13.3% 0.0% 0.0%   ROI %   32.1% 41.4% 41.6% 43.3% 41.3% 24.9% 0.0% 0.0%   ROE %   51.4% 65.6% 58.3% 49.0% 44.6% 28.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   31.9% 31.0% 29.8% 38.0% 32.4% 23.9% 70.0% 70.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   96.8% 97.2% -72.7% -36.2% 54.3% 117.1% 0.0% 0.0%   Gearing %   90.6% 92.0% 1.3% 1.2% 47.6% 119.2% 42.8% 42.8%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.8% 4.9% 6.4% 189.6% 17.2% 4.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 1.2 1.4 1.6 1.3 1.2 0.0 0.0   Current Ratio   1.0 1.1 1.4 1.7 1.3 1.2 0.0 0.0   Cash and cash equivalent   63.9 10.7 1,422.7 679.8 265.6 332.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1.5 600.8 1,820.0 2,021.0 1,136.3 1,026.7 -159.7 -159.7   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   46 50 55 51 51 48 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   46 50 55 51 48 48 0 0   EBIT / employee   36 42 46 44 44 44 0 0   Net earnings / employee   27 33 37 35 32 18 0 0